Inventor · name-matched record
SCHIENEBECK CASI
0 granted patents·4 pending applications·0 citations·filing 2025–2025
Technology areasC12N
Files withARROWHEAD PHARMACEUTICALS INC4
This identity is grouped by exact name match (no disambiguated inventor record was available for these filings) — it may combine same-named inventors.
Top patents by PatentIndex Score
4 records- 0170US2026022379A1Optimized RNAi Agents for Inhibiting Expression of Coronavirus (CoV) Viral Genomes, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0270US2026022381A1RNAi Agents for Inhibiting Expression of Complement Factor B (CFB), Pharmaceutical Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0357US2026043029A1RNAi Agents for Inhibiting Expression of Thymic Stromal Lymphopoietin (TSLP), Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 0456US2026078375A1RNAi Agents for Inhibiting Influenza A Viral Gene Expression, Compositions Thereof, and Methods of UseARROWHEAD PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCHIENEBECK CASI files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: exact name match across USPTO filings. How scoring works →